Etablissement Français du Sang

The core business of EFS’ bioproduction teams is to offer a full range of services aimed at making ATMPs accessible to patients with unmet medical needs. EFS’ expertise provides you with a real support on development stages, scaling up and GMP-compliant manufacturing of your preclinical and clinical batches ; EFS also acts as an interface between research and clinical teams. Besides, the EFS Bourgogne Franche-Comté (BFC) Biotherapies Innovation Centre (PIBT) has been awarded the “Biotherapies – Bioproduction Integrator” label in May 2023. Located in an ecosystem conducive to Biomanufacturing, the PIBT supports your projects to develop biomedicines derived from immune cells (LT, LB, NK, CAR-cells, CSM, among other examples) or to innovate production processes, drawing on its scientific, technical and regulatory skills, as well as its project management skills. We also accompany technology developers in advancing the maturity of their innovative solutions in the bioproduction field and enabling their integration into bioprocesses. EFS’ teams take part in collaborative projects or provides services for third parties, depending on the needs of the players involved.